| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |